藥劑部首頁

電子處方集
處方集PDA版
藥物交互作用查詢
健保給付規定
藥劑簡訊通告
不良反應通報系統
意見信箱
 Vancomycin HCl

點小圖看大圖

11V020, 500 mg/Vial現行藥物外觀

中文名:利凡凍晶靜脈注射劑

廠牌:中國化學

Product name
Vancomycin
Dosage form
 11V020, 500 mg/Vial
Indications
Dental procedure - Endocarditis - Prophylactic antibiotic therapy; Endocarditis; Endocarditis - Procedure on digestive system - Prophylactic antibiotic therapy - Urogenital system investigation; Peritoneal dialysis-associated peritonitis; Pseudomembranous enterocolitis; Staphylococcal enterocolitis; Streptococcus group B infection of the infant; Prophylaxis Meningitis
Administration & Dosage

Vancomycin HCl
 Vancomycin HCl

點小圖看大圖

11V020, 500 mg/Vial現行藥物外觀

中文名:利凡凍晶靜脈注射劑

廠牌:中國化學

Product name
Vancomycin
Dosage form
 11V020, 500 mg/Vial
Indications
Dental procedure - Endocarditis - Prophylactic antibiotic therapy; Endocarditis; Endocarditis - Procedure on digestive system - Prophylactic antibiotic therapy - Urogenital system investigation; Peritoneal dialysis-associated peritonitis; Pseudomembranous enterocolitis; Staphylococcal enterocolitis; Streptococcus group B infection of the infant; Prophylaxis Meningitis
Administration & Dosage

Indication& Dosage:

Adult:

Usual dosage range:

Initial intravenous dosing should be based on actual body weight; subsequent dosing adjusted based on serum trough vancomycin concentrations.

I.V.: 2000-3000 mg daily (or 30-60 mg/kg/day) in divided doses every 8-12 hours

Note: Dose requires adjustment in renal impairment

Oral: 500-2000 mg daily in divided doses every 6 hours

Indication-specific dosing:

C. difficile -associated diarrhea (CDAD):

Oral:Mild to moderate disease unresponsive to metronidazole: 125 mg 4 times daily for 10 days Severe, complicated infection: 500 mg every 6 hours for 10-14 days with or without concurrent I.V. metronidazole. May consider vancomycin retention enema (in patients with complete ileus)

Complicated infections in seriously-ill patients:

I.V.: Loading dose: 25-30 mg/kg (based on actual body weight) may be used to rapidly achieve target concentration; then 15-20 mg/kg/dose every 8-12 hours

Meningitis:

I.V.: 30-60 mg/kg/day in divided doses every 8-12 hours or 500-750 mg every 6 hours (with third-generation cephalosporin for PCN-resistant Streptococcus pneumoniae)

Alternate regimen: S. aureus (methicillin-resistant): 15-20 mg/kg/dose every 8-12 hours for 2 weeks (some experts combine with rifampin)

Intrathecal, intraventricular (unlabeled route): 5-20 mg/day

Pneumonia:

I.V.:Community-acquired pneumonia (CAP): S. aureus (methicillin-resistant): 45-60 mg/kg/day divided every 8-12 hours (maximum: 2000 mg/dose) for 7-21 days depending on severity Healthcare-associated pneumonia (HAP): S. aureus (methicillin-resistant): 45-60 mg/kg/day divided every 8-12 hours (maximum: 2000 mg/dose) for 7-21 days depending on severity

Susceptible (MIC 1 mcg/mL) gram-positive infections:

I.V.:15-20 mg/kg/dose (usual: 750-1500 mg) every 8-12 hours. Note: If MIC ≧2 mcg/mL, alternative therapies are recommended.

Pediatric:

Usual dosage range:

Infants >1 month and Children: I.V.: 10-15 mg/kg every 6 hours

Indication-specific dosing:

C. difficile -associated diarrhea (CDAD):

Infants >1 month and Children: Oral: 40 mg/kg/day in 3-4 divided doses for 7-10 days (maximum: 2000 mg/day)

Meningitis:

Infants >1 month and Children: I.V.: 15 mg/kg every 6 hours

Alternate regimen: S. aureus (methicillin-resistant): 15-20 mg/kg/dose every 8-12 hours for 2 weeks (some experts combine with rifampin)

Intrathecal, intraventricular (unlabeled route): 5-20 mg/day

Pneumonia:

Group A Streptococcus, S. aureus, moderate-to-severe infection : 40-60 mg/kg/day divided every 6-8 hours

Healthcare-associated pneumonia (HAP), S. aureus (methicillin-resistant): I.V.: Infants and Children: 60 mg/kg/day divided every 6 hours for 7-21 days depending on severity

Susceptible gram-positive infections (MIC 1 mcg/mL):

I.V.: Infants >1 month and Children: 10 mg/kg/dose every 6 hours or 15 mg/kg/dose (maximum: 2000 mg/dose) every 6 hours . Note: If MIC ≧2 mcg/mL, alternative therapies are recommended.

Contraindication
hypersensitivity to vancomycin products.
Precaution
 
Adverse reaction
L: Nephrotoxicity; neutropenia; “red man syndrome”( may result from histamine release due to rapid infusion) 
Drug Interaction
 
Pregnancy Category
 C
Notes
1.IV dilute to at least 5 mg/mL, infuse over at least 60 min (rate≦ 10 mg/min); increase infusion time to 1.5-2 hrs in patients experiencing red man syndrome. 2. If the intravenous formulation is used for oral administration, dilute in 1 ounce of water.  
最近更新日期 2015年9月24日